Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.24.3
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2024
STOCK-BASED COMPENSATION  
Summary of the expense for stock-based compensation related to stock option grants

Three Months Ended

Six Months Ended

June 30, 

June 30, 

    

2024

    

2023

    

2024

    

2023

Employee and director stock option grants:

 

  

 

  

 

  

 

  

Research and development

$

74,450

$

72,529

$

143,225

$

138,724

General and administrative

 

724,799

 

347,228

 

1,110,387

 

689,239

Total stock-based compensation

$

799,249

$

419,757

$

1,253,612

$

827,963